Lloyds Pharmacy news

McKesson is to sell its UK businesses, including LloydsPharmacy and AAH, to pan-European asset management group, AURELIUS. McKesson looking to invest in strategic growth outside of Europe The deal includes the sale of LloydsPharmacy, LlyodsDirect, AAH Pharmaceuticals, LloydsPharmacy Clinical Homecare, LloydsPharmacy Online Doctor, MASTA and John Bell & Croyden for £477m. McKesson announced ...

In a report filed to Companies House, LloydsPharmacy announces a 0.6% growth to £2.16bn in the year to 31st March 2018. FY2017: turnover flat, profit declines LloydsPharmacy has reported a 0.6% growth in turnover to £2.16bn for the year to 31st March 2018. The company is owned by US-based healthcare conglomerate McKesson UK, formerly Celesio UK. The result marks a reverse in performan...

Sainsbury's has won regulatory approval from the Competition and Markets Authority for the sale of its pharmacy business to Celesio, the owner of LloydsPharmacy. The approval is conditional upon the divestiture of a LloydsPharmacy store in 12 areas where the regulator ruled that local competition would be adversely impacted by the merger. LloydsPharmacy to acquire Sainsbury's pharmacies The...

The Competition & Markets Authority (CMA) has referred Sainsbury's proposed sale of its pharmacy business to Lloydspharmacy, Celesio's UK pharmacy business, for an in depth "phase 2" investigation. The move follows the completion of an initial investigation which identified 78 local areas in which the CMA concluded customers could be adversely affected by a loss of competition between the two ret...

Sainsbury's has struck a deal to set up a strategic partnership with LloydsPharmacy owner Celesio that will see LloydsPharmacy acquire Sainsbury's pharmacy business. Sainsbury's to gain rental payments from pharmacies The deal will see LloydsPharmacy buy Sainsbury's 277 in-store and four hospital pharmacies for £125m with Sainsbury's receiving commercial rent payments for each location. Al...

Germany-based Celesio has announced preliminary full year results for its 2014 fiscal year saying that revenues rose 4.2% in constant currency terms to €22.3 billion, driven by the performance of its consumer solutions division. Performance by division Celesio said that by at its Consumer solutions division, which includes its retail pharmacy business, revenue rose by 5.5% at constant exchang...

Celesio has reported revenue growth of 1.8% for the first half of 2014. It saw a decrease in adjusted EBIT of 1.7% due to continued discount competition in Germany and an adverse performance in Brazil.  Maintained forecast despite headwinds Celesio saw revenue increase by 1.8% to €10,930.8mn, while adjusted for currency effects and changes in the consolidation group, revenue rose by 3...

Celesio has announced a slight fall in sales for the fiscal year 2013 while reporting continuing progress in its broader strategy. Group revenue decrease by 3.9% Total group revenue declined by 3.9% from €22,270m to €21,407m in 2013. Celesio attributes the deconsolidation of the Czech operations in November 2012 and the Irish wholesale operation in May 2013, along with currency effects, to this...

German drugstore group Celesio has announced a drop in sales for its third quarter. Fall in sales due to competitive home market Celesio reported group sales to have fallen by 4.2% to €16bn. They also announced a drop of 12.5% in adjusted pre-tax profit to €206.4m and a fall of 6.6% in adjusted operating profit to €312m. The group’s wholesale Pharmacy Solutions division reported a drop of ...

McKesson, America's largest drug wholesaler, has announced a deal worth US$8.3 billion to acquire Celesio to forge a global market leader. End of speculation Having reached an agreement with Celesio's current owners, holding company Franz Haniel, McKesson's announcement has ended months of speculation surrounding the future of the Germany-based company. The deal sees McKesson acquiring 50....